Dimensional Fund Advisors’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-61,542
Closed -$122K 3306
2025
Q2
$122K Hold
61,542
﹤0.01% 3169
2025
Q1
$89.6K Sell
61,542
-405
-0.7% -$749 ﹤0.01% 3213
2024
Q4
$128K Sell
61,947
-10,634
-15% -$20K ﹤0.01% 3214
2024
Q3
$128K Sell
72,581
-80,021
-52% -$205K ﹤0.01% 3220
2024
Q2
$2.2M Buy
152,602
+36,690
+32% +$504K ﹤0.01% 2739
2024
Q1
$1.93M Buy
115,912
+51,347
+80% +$821K ﹤0.01% 2799
2023
Q4
$1.04M Buy
+64,565
New +$858K ﹤0.01% 2929

Dimensional Fund Advisors's HLVX Position: Q3 2025 in Review

Dimensional Fund Advisors sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 61,542 shares — an estimated $122K sold.

Dimensional Fund Advisors first reported a position in HLVX in Q4 2023 and held it in 7 quarters. The position peaked at $2.2M in Q2 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Dimensional Fund Advisors reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 61,542 HilleVax shares in Q3 2025, an estimated $122K.
  • Dimensional Fund Advisors first reported a position in HilleVax in Q4 2023 and held it in 7 quarters.
  • Dimensional Fund Advisors's HilleVax position peaked at $2.2M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.